News Focus
News Focus
icon url

DewDiligence

12/22/11 10:25 AM

#133577 RE: DewDiligence #133498

Factoid: MNTA is now trading above the 10-day trailing average immediately prior to Amphastar’s FDA approval on 9/19/11, which was $16.85.
icon url

DewDiligence

12/22/11 11:35 PM

#133654 RE: DewDiligence #133498

Quiz: Why was it perfectly legal for MNTA’s Chairman to execute an insider transaction (#msg-70171811) only three days before MNTA announced a partnership deal?